AWS HealthOmics customers

Using AWS HealthOmics, we can further our understanding of biology, target, and disease, ultimately informing decisions in Research and Development. For a company of Amgen’s size, having everything in one place is tremendous for reproducibility, transparency, security, and permissions.

Our bioinformaticians no longer need hand-holding. For example, we use AWS HealthOmics to cut the time to complete analysis for cancer research from 1 year to 3 months. That’s the value that we’re getting right now.

At Children’s Hospital of Philadelphia, we know that getting a comprehensive view of our patients is crucial to delivering the best possible care, based on the most innovative research. Combining multiple clinical modalities is foundational to achieving this. With AWS HealthOmics, we can expand our understanding of our patients’ health, all the way down to their DNA.

In C2i Genomics, we empower our data scientists by providing them cloud-based computational solutions to run high-scale, customizable genomic pipelines, allowing them to focus on method development and clinical performance, while the company’s engineering teams are responsible for the operations, security, and privacy aspects of the workloads. AWS HealthOmics allows researchers to use tools and languages from their own domain and considerably reduces the engineering maintenance effort while taking care of cost and resource allocation considerations, which, in turn, reduce time-to-market and NRE costs of new features and algorithmic improvements.

AWS HealthOmics allows G42 to accelerate a competitive and deployable end-to-end service with globally leading data governance. We’re able to leverage the extensive omics data management and bioinformatics solutions hosted globally on AWS, at our customers’ fingertips. Our collaboration with AWS is much more than data—it’s about value.

At Ovation, we want to make it easier for patients to live long and healthy lives by accessing therapeutics that are tailored to their needs. Being a part of the AWS HealthOmics genomic variant store helps us achieve that mission by getting our genomic data into the hands of researchers faster and at scale. We’re excited to be building a team of industry experts and partners like AWS that are helping personalized medicines get to market quicker.

Element Biosciences is opening the world of biology to new possibilities through Element's AVITI system. AWS HealthOmics provides a simple solution for running workflows in the cloud and this will enable the scientific community to easily process their sequencing data without the need to set up any infrastructure, allowing them to focus on their research.

Ultima Genomics is unleashing the power of genomics at scale. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. We are excited to work with AWS to help our customers to scale secondary analysis with AWS HealthOmics.

At Sentieon, we are dedicated to enabling precision data for precision medicine. AWS HealthOmics simplifies the infrastructure setup to run Sentieon’s suite of bioinformatics secondary analysis tools. We look forward to offering our analysis workflows on AWS HealthOmics.

BioTeam is a life sciences IT consulting company passionate about accelerating scientific discovery by closing the gap between what scientists want to do with data and what they can do. We look forward to utilizing AWS HealthOmics as one of our tools to help simplify automating the collection, organization, and transformation of data from large genomic sequencing efforts for our clients.

At Lifebit, we’re on a mission to connect the world’s biomedical data to obtain novel therapeutic insights. Our customers work with vast cohorts of linked genomic, multi-omics and clinical data - and these data volumes are expanding rapidly. With AWS HealthOmics they will have access to optimised analytics and storage for this large-scale data, allowing us to provide even more scalable bioinformatics solutions. Our customers will benefit from significantly lower cost per gigabase of data, essentially achieving hot storage performance at cold storage prices, removing cost as a barrier to generating insights from their population-scale biomedical data.

With AWS HealthOmics, we are able to provide biotech and pharma companies with advanced analytics to accelerate drug discovery and cut research study timelines by 70%.